These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 37799251)
1. Daptomycin-Induced Severe Hyperkalemia With Normal Creatine Kinase in a Patient With Methicillin-Resistant Staphylococcus aureus Osteomyelitis. Sawhney KK; Oluyadi F Cureus; 2023 Sep; 15(9):e44674. PubMed ID: 37799251 [TBL] [Abstract][Full Text] [Related]
2. Daptomycin-Related Rhabdomyolysis Complicated by Severe Hyperkalemia and Acute Kidney Injury. Nishimura Y Cureus; 2022 Sep; 14(9):e29764. PubMed ID: 36324366 [TBL] [Abstract][Full Text] [Related]
3. Daptomycin-Induced Hyperkalemia as an Early Sign of Rhabdomyolysis in a Diabetic Patient. Ibarra G; Elmaaz A; Hennel D; Pacheco E Cureus; 2020 Nov; 12(11):e11674. PubMed ID: 33391911 [TBL] [Abstract][Full Text] [Related]
4. Rapid Aggravation of Rhabdomyolysis Caused by Daptomycin After Aortic Arch Replacement: A Case Report. Takechi K; Fujimoto M; Abe T; Shimizu I Cureus; 2024 Feb; 16(2):e53611. PubMed ID: 38449986 [TBL] [Abstract][Full Text] [Related]
5. Successful Daptomycin Use in a Pediatric Patient With Acute, Bilateral Osteomyelitis Caused by Methicillin-Resistant Staphylococcus aureus. Billups KL; Stultz JS J Pediatr Pharmacol Ther; 2015; 20(5):397-402. PubMed ID: 26472955 [TBL] [Abstract][Full Text] [Related]
6. Methicillin-resistant Staphylococcus aureus (MRSA) mitral valve acute bacterial endocarditis (ABE) in a patient with Job's syndrome (hyperimmunoglobulin E syndrome) successfully treated with linezolid and high-dose daptomycin. Cunha BA; Krol V; Kodali V Heart Lung; 2008; 37(1):72-5. PubMed ID: 18206530 [TBL] [Abstract][Full Text] [Related]
7. Daptomycin-induced hyperkalemia: A case report and brief description of mechanism. Errabelli P; Lathiya M; Roy S Clin Case Rep; 2023 Nov; 11(11):e8188. PubMed ID: 37965183 [TBL] [Abstract][Full Text] [Related]
8. Dosing strategy to allow continued therapy with daptomycin after asymptomatic increases in creatine kinase levels. Burdette SD; Oleson F; McDaneld PM; Benziger D; Patel HN Am J Health Syst Pharm; 2014 Jul; 71(13):1101-7. PubMed ID: 24939500 [TBL] [Abstract][Full Text] [Related]
9. Possible Hepatotoxicity Associated With Daptomycin: A Case Report and Literature Review. Mo Y; Nehring F; Jung AH; Housman ST J Pharm Pract; 2016 Jun; 29(3):253-6. PubMed ID: 26763341 [TBL] [Abstract][Full Text] [Related]
10. Normalization of creatine kinase values in a case of rhabdomyolysis during daptomycin treatment. Ferrández O; Urbina O; Luque S; Espona M; Berenguer N; Grau S Indian J Pharmacol; 2013; 45(2):193-4. PubMed ID: 23716901 [TBL] [Abstract][Full Text] [Related]
11. Muscle pain associated with daptomycin. Veligandla SR; Louie KR; Malesker MA; Smith PW Ann Pharmacother; 2004 Nov; 38(11):1860-2. PubMed ID: 15367725 [TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of daptomycin (LY146032) and vancomycin in the treatment of experimental methicillin-resistant Staphylococcus aureus osteomyelitis in rabbits. Mader JT; Adams K Antimicrob Agents Chemother; 1989 May; 33(5):689-92. PubMed ID: 2546488 [TBL] [Abstract][Full Text] [Related]
13. Daptomycin-induced hyperkalemia in a patient with normal renal function. Budovich A; Blum S; Berger B Am J Health Syst Pharm; 2014 Dec; 71(24):2137-41. PubMed ID: 25465585 [TBL] [Abstract][Full Text] [Related]
14. Exebacase in Addition to Daptomycin Is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats. Karau MJ; Schmidt-Malan SM; Yan Q; Greenwood-Quaintance KE; Mandrekar J; Lehoux D; Schuch R; Cassino C; Patel R Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31358593 [TBL] [Abstract][Full Text] [Related]
15. High-dose, short-interval daptomycin regimen was safe and well tolerated in three patients with chronic renal failure. Yabuno K; Seki M; Miyawaki K; Miwa Y; Tomono K Clin Pharmacol; 2013; 5():161-6. PubMed ID: 24235850 [TBL] [Abstract][Full Text] [Related]
16. Daptomycin-induced acute renal and hepatic toxicity without rhabdomyolysis. Abraham G; Finkelberg D; Spooner LM Ann Pharmacother; 2008 May; 42(5):719-21. PubMed ID: 18381844 [TBL] [Abstract][Full Text] [Related]
17. Combination of ceftaroline and daptomycin as treatment for complicated osteomyelitis. Gascón A; Castresana M; Alzueta N; Marin M; Pío M; Echeverria A Eur J Hosp Pharm; 2021 Sep; 28(5):289-292. PubMed ID: 32414746 [TBL] [Abstract][Full Text] [Related]
18. Long-term use of daptomycin for MRSA osteomyelitis and joint infection. Burns CA Scand J Infect Dis; 2008; 40(2):183-6. PubMed ID: 17852899 [TBL] [Abstract][Full Text] [Related]
19. Methicillin-resistant Staphylococcal periprosthetic joint infections can be effectively controlled by systemic and local daptomycin. Kuo FC; Yen SH; Peng KT; Wang JW; Lee MS BMC Infect Dis; 2016 Feb; 16():48. PubMed ID: 26830838 [TBL] [Abstract][Full Text] [Related]
20. Implementation of an antimicrobial stewardship pathway with daptomycin for optimal treatment of methicillin-resistant Staphylococcus aureus bacteremia. Kullar R; Davis SL; Kaye KS; Levine DP; Pogue JM; Rybak MJ Pharmacotherapy; 2013 Jan; 33(1):3-10. PubMed ID: 23307539 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]